🇺🇸 FDA
Pipeline program

ETOPOSIDE , DEXAMETHASONE

APHP230874

Phase 3 small_molecule active

Quick answer

ETOPOSIDE , DEXAMETHASONE for Hemophagocytic lymphohistiocytosis (HLH) is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Pari Pharma GmbH
Indication
Hemophagocytic lymphohistiocytosis (HLH)
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials